Ownership Neutral

2026-08-24 19:26

- On August 24, 2026, the Nomination and Remuneration Committee approved the allotment of 25,691 equity shares of Rs. 2/- each to employees upon the exercise of ESOPs. - The issued and subscribed share capital increased to Rs. 455,161,426, comprising 227,580,713 equity shares.

Business Update Positive

2026-08-14 13:19

- Zensar completed requisite filings for the merger of its US-based 100% step-down subsidiaries, M3BI LLC and Bridgeview Life Sciences LLC, with Zensar Technologies Inc., USA. The merger of M3BI LLC will be effective from September 1, 2026.

Business Update Neutral

2026-08-10 13:47

- Investor Meeting Schedule - Date: August 13, 2026, Time: 1:00 p.m. onwards, Event: Equirus Annual India Conference 2026 (In Person Group Meeting) - Date: August 14, 2026, Time: 10:00 a.m. onwards, Event: Emkay Confluence 2026 – India: Full Throttle Ahead

Business Update Neutral

2026-08-10 13:29

- Zensar Technologies Limited will participate in investor meetings as per the following schedule: - Investor Meeting 1: Equirus Annual India Conference 2026 - Date: August 13, 2026 - Time: 1:00 p.m. onwards - Investor Meeting 2: Emkay Confluence 2026 – India: Full Throttle Ahead - Date: August 14, 2026 - Time: 10:00 a.m. onwards - No unpublished price sensitive information will be shared during these meetings.

Business Update Positive

2026-08-08 14:19

- Crisil assigned Zensar Technologies an overall ESG Score of 74 under the 'Leadership' category for FY26. - The rating reflects the Company's strong performance on ESG parameters.

Business Update Neutral

2026-08-05 20:59

- Earnings Call Transcript for Q1FY27 results made available on the company website. - The call was held on July 30, 2026, discussing financial results for the quarter ended June 30, 2026.

Governance Positive

2026-07-31 17:44

- The 63rd Annual General Meeting (AGM) held on July 30, 2026, passed all resolutions with requisite majority. - This included approving FY26 financials, confirming an interim dividend of ₹2.40 and declaring a final dividend of ₹12.60 per share for FY26. - Re-appointment of H. V. Goenka and approval of ₹7,500 million Material Related Party Transactions for FY27 were also passed.

Business Update Neutral

2026-07-31 14:51

- Filings for the merger of Bridgeview Life Sciences LLC with Zensar Technologies Inc. (USA) are complete. - This merger will be effective from August 1, 2026. - Filings for the merger of M3BI LLC with Zensar Technologies Inc. are currently in progress.

Governance Neutral

2026-07-30 17:24

- The 63rd Annual General Meeting (AGM) of Zensar Technologies Limited was held on Thursday, July 30, 2026, at 3:30 P.M. (IST). - Key business conducted included adoption of FY26 financial statements, confirmation of interim dividend, declaration of final dividend, re-appointment of H. V. Goenka, and approval of material related party transactions worth INR 7,500 Million for FY27.

Business Update Neutral

2026-07-30 11:22

- Audio recording of the Q1FY27 Results Earnings Call, held on July 30, 2026, at 08:30 AM (IST), is now available on Zensar Technologies Limited's website under the 'Investors Corner' section.

Business Update Positive

2026-07-29 20:31

- Board accorded in-principle approval for the merger of two US-based step-down subsidiaries, Bridgeview Life Sciences LLC and M3BI LLC, into Zensar Technologies Inc., USA, a wholly-owned subsidiary. The merger aims to achieve greater business synergies and operational efficiencies. It will not change the listed entity's shareholding pattern.

Financials Neutral

2026-07-29 20:27

- Consolidated Revenue ₹15,083Mn vs ₹13,850Mn (▲8.9% YoY) - EBITDA ₹2,208Mn vs ₹2,106Mn (▲4.8% YoY) - PAT ₹1,838Mn vs ₹1,820Mn (▲1.0% YoY) - EBITDA Margin 14.6% vs 15.2% (▼60bps)

Financials Neutral

2026-07-29 20:16

- Consolidated Revenue ₹15,083Mn vs ₹13,850Mn (▲8.9% YoY) - EBITDA ₹2,209Mn vs ₹2,106Mn (▲4.9% YoY) - PAT ₹1,838Mn vs ₹1,820Mn (▲1.0% YoY) - EBITDA Margin 14.7% vs 15.2% (▼56bps)

Business Update Neutral

2026-07-27 10:01

- Concall Schedule - Concall Date: July 30, 2026 - Concall Time: 8:30 AM IST

Ownership Neutral

2026-07-20 22:02

- On July 20, 2026, the Nomination and Remuneration Committee approved the allotment of 21,130 fully paid equity shares of Rs. 2/- each to employees against the exercise of ESOPs. - Consequently, the issued and subscribed share capital increased to 227,555,022 equity shares of Rs. 2/- each.

Business Update Positive

2026-07-20 21:58

- Zensar Technologies granted 6,28,502 stock options to eligible employees under 'Zensar - Employees Stock Option Scheme 2025'. - The exercise price is ₹2 per option (face value). - The grant was approved by the Nomination and Remuneration Committee on July 20, 2026.

Governance Neutral

2026-07-08 16:28

- The 63rd Annual General Meeting (AGM) of Zensar Technologies Limited is scheduled for Thursday, July 30, 2026, at 03:30 P.M. (IST) via Video Conference. - The Integrated Annual Report for FY2025-26 has been dispatched. - The Record date for Final Dividend is Friday, July 17, 2026. - Dividend payment is on or before August 29, 2026.

Governance Positive

2026-07-08 15:55

- Zensar Technologies Limited will hold its 63rd Annual General Meeting on Thursday, July 30, 2026, at 03:30 P.M. (IST) via Video Conferencing/OAVM. - Key agenda items include adoption of FY2025-26 accounts, declaration of a Final Dividend of INR 12.60 per equity share (totaling INR 15.00 with interim), re-appointment of H. V. Goneka, and approval of material related party transactions.

Financials Positive

2026-06-30 16:40

- Intimation of 63rd AGM on July 30, 2026, at 3:30 P.M. (IST) via VC/OAVM. - Board recommended a final dividend of ₹12.60 per Equity share for FY26, subject to AGM approval. - Record Date for the final dividend is July 17, 2026.

Governance Positive

2026-06-30 16:32

- The 63rd Annual General Meeting (AGM) will be held on July 30, 2026, at 3:30 P.M. (IST). - A final dividend of Rs. 12.60 per equity share for FY2025-26 has been recommended. - The Record Date for the dividend is July 17, 2026.

Routine Neutral

2026-06-29 16:04

- Trading window closed from July 1, 2026, for designated persons to consider Unaudited Financial Results for the quarter ended June 30, 2026. - Window will reopen 48 hours after results declaration.

Ownership Positive

2026-06-16 19:11

- Nomination and Remuneration Committee approved allotment of 38,238 fully paid equity shares of Rs. 2/- each on June 16, 2026. - Shares allotted to employees against the exercise of ESOPs. - Consequently, the issued and subscribed share capital increased to 227,533,892 equity shares.

Governance Positive

2026-06-15 21:17

- Zensar Technologies Limited announced the appointment of Mr. Brahma Pandey as Senior Vice President (Senior Management Personnel) with effect from June 15, 2026. - Mr. Pandey brings over 25 years of experience in the technology services industry, including his previous role as VP & Head of Sales at Infosys, with a focus on strategic growth.

ZENSARTECH

Zensar Technologies Limited

Price Chart

Filing History

Unlock Full History